Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol aerosol effects on sevoflurane dynamics and early postoperative pulmonary complications in COPD patients under general anesthesia
ChiCTR1900022899Phase 4Not yet recruiting
- Sponsor
- Shaoxing People's Hospital
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of salbutamol and sevoflurane in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Shaoxing People's Hospital. Primary endpoint: End-tidal concentration of sevoflurane. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
salbutamolsevoflurane
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR1900022899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022899.